Since 2003, I have developed medical communications in a broad range of therapeutic areas, with an emphasis on orphan indications. I focus on the effective presentation of research findings and value messages, including for such specialized topics as pharmacoeconomics, retrospective database analysis, and patient-reported outcomes. I support the development of global value dossiers, articles for peer-reviewed biomedical journals, model reports, and conference abstracts, posters and slide decks.=====ABOUT MARK ROBERTSVice President, Medical Communications at STRATENYM INC.Mark is an expert on effective presentation of research findings, including for such specialized topics as cost-effectiveness analysis, retrospective database analysis, and patient-reported outcomes. Successfully transitioning from academia to industry in 2003, Mark has built deep experience in developing medical communications in a broad range of therapeutic areas, with a strong focus on orphan indications.Over his long career in the field, Mark has supported the development of global value dossiers, strategy documents to help companies differentiate their products from the competition, articles for peer-reviewed biomedical journals, pharmacoeconomic model reports, and conference abstracts, posters and slide decks.From 2006–2009, Mark was the Managing Editor at IC Axon, where he supervised the medical writer team creating content for innovative sales training for clients in the pharmaceutical industry. Prior to this position, Mark was a Senior Research Application Associate at BioMedCom Consultants, where he developed projects for clients in industry and academia. He has also taught courses in biostatistics and experimental methods at McGill University.
